Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5734389 | Surgery | 2017 | 11 Pages |
Abstract
Neoadjuvant chemotherapy, including monoclonal antibodies, does not negatively affect future liver remnant growth. Patients with colorectal liver metastases who might be potential candidates for associating liver partition and portal vein ligation for staged hepatectomy should be considered for neoadjuvant chemotherapy.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
Kristina MD, Massimo MD, Soumil MS, FRCS, Ricardo Robles MD, PhD, Roberto MD, Michael MD, Henrik MD, Pierre Alain MD, PhD, Marcel Autran MD, FACS, Roberto MD, FACS, FRCSC, Kerollos MD, Lars MSc, Per MD, PhD, Bergthor MD, PhD,